Piotr Rutkowski

4 ta ish

The Maria Sklodowska-Curie National Research Institute of Oncology

1. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

   James Larkin, Vanna Chiarion‐Sileni, René González +28

   MaqolaOAOchiq kirish20153 iqtibos

   ABIABI:AkademIndex/2026.other.170114

2. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

   Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González +30

   MaqolaOAOchiq kirish20172 iqtibos

   ABIABI:AkademIndex/2026.other.082822

3. Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

   Caroline Robert, Georgina V. Long, Benjamin Brady +25

   MaqolaOAOchiq kirish20142 iqtibos

   ABIABI:AkademIndex/2026.other.241891

4. From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma

   Kamil J. Synoradzki, Natalia Paduszyńska, Małgorzata Solnik +10

   Maqola20242 iqtibos

   ABIABI:AkademIndex/2026.other.472168